UK markets closed


Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
15.680.00 (0.00%)
As of 02:47PM EST. Market open.


Surrey Research Park
10 Nugent Road
Guildford GU2 7AF
United Kingdom
44 14 8334 3434

IndustryDiagnostics & Research
Full-time employees102

Key executives

NameTitlePayExercisedYear born
Mr. Andrew David William NewlandFounder, CEO & Exec. Director531.35kN/A1962
Mr. Ian Francis GriffithsCFO, Fin. Director, Company Sec. & Exec. Director340.23kN/A1965
Mr. Andrew John HolderHead of Investor RelationsN/AN/AN/A
Dr. Madeline RepolletHead of Clinical LaboratoriesN/AN/AN/A
Ms. Anne-Sophie Pailhes-JimenezHead of R&D - ANGLE Europe Ltd.N/AN/AN/A
Dr. Todd DruleyChief Medical OfficerN/AN/AN/A
Mr. Paul SmithVP & Chief Exec. Officer of ANGLE Biosciences IncN/AN/AN/A
Mr. Martin CookeDirector of Manufacturing & Regulatory AffairsN/AN/A1969
Mr. Michael O'BrienBus. Devel. DirectorN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application. It also offers specialist circulating tumor cell enrichment and analysis services to support translational research studies and pharmaceutical trials. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Corporate governance

ANGLE plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.